United Kingdom (UK) CRISPR and CAS Genes Market (2025-2031) | Segmentation, Trends, Outlook, Forecast, Industry, Companies, Growth, Value, Analysis, Size & Revenue, Competitive Landscape, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) CRISPR and CAS Genes Market - Industry Life Cycle

3.4 United Kingdom (UK) CRISPR and CAS Genes Market - Porter's Five Forces

3.5 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development in the field of CRISPR and Cas genes technology

4.2.2 Growing demand for personalized medicine and gene therapy in the UK

4.2.3 Rising prevalence of genetic disorders and chronic diseases driving the need for advanced gene editing technologies

4.3 Market Restraints

4.3.1 Stringent regulations and ethical concerns surrounding the use of CRISPR and Cas genes in humans

4.3.2 Lack of awareness and understanding among healthcare professionals and patients about the potential benefits of CRISPR and Cas gene editing technology

6.1 United Kingdom (UK) CRISPR and CAS Genes Market, By Product

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Vector-based Cas, 2021- 2031F

6.1.4 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By DNA-free Cas, 2021- 2031F

6.2 United Kingdom (UK) CRISPR and CAS Genes Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Genome Engineering, 2021- 2031F

6.2.3 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Disease Models, 2021- 2031F

6.2.4 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Functional Genomics, 2021- 2031F

6.2.5 United Kingdom (UK) CRISPR and CAS Genes Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) CRISPR and CAS Genes Market Export to Major Countries

7.2 United Kingdom (UK) CRISPR and CAS Genes Market Imports from Major Countries

8.1 Number of research grants allocated for CRISPR and Cas genes studies in the UK

8.2 Percentage increase in the adoption of CRISPR and Cas gene editing techniques in clinical trials and medical research

8.3 Rate of growth in the number of partnerships and collaborations between biotech companies and research institutions in the UK for CRISPR and Cas genes research and development.

9.1 United Kingdom (UK) CRISPR and CAS Genes Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United Kingdom (UK) CRISPR and CAS Genes Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United Kingdom (UK) CRISPR and CAS Genes Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) CRISPR and CAS Genes Market Competitive Benchmarking, By Operating and Technical Parameters